Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$994M |
| 2 |
Cigna
CI
|
+$524M |
| 3 |
Microsoft
MSFT
|
+$395M |
| 4 |
Amazon
AMZN
|
+$281M |
| 5 |
CVS Health
CVS
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$918M |
| 2 |
AET
Aetna Inc
AET
|
+$761M |
| 3 |
PX
Praxair Inc
PX
|
+$581M |
| 4 |
COL
Rockwell Collins
COL
|
+$274M |
| 5 |
CA
CA, Inc.
CA
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.41% |
| 3 | Healthcare | 13.78% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
1901
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $12.8M | ﹤0.01% |
228,682
-3,809
| -2% | -$233K |
|
1902
Cactus
WHD
$5.78B
| $12.8M | ﹤0.01% |
467,374
-5,701
| -1% | -$187K |
|
|
GTT
1903
DELISTED
GTT Communications, Inc.
GTT
| $12.8M | ﹤0.01% |
540,626
-8,714
| -2% | -$293K |
|
|
BHVN
1904
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.8M | ﹤0.01% |
345,633
-636
| -0.2% | -$22.9K |
|
|
NBIS
1905
Nebius Group N.V.
NBIS
$49.1B
| $12.8M | ﹤0.01% |
466,869
+290,332
| +164% | +$8.52M |
|
1906
Stewart Information Services
STC
$2B
| $12.8M | ﹤0.01% |
308,336
-3,192
| -1% | -$134K |
|
|
FIT
1907
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $12.7M | ﹤0.01% |
2,563,708
+48,103
| +2% | +$248K |
|
1908
Ingersoll Rand
IR
$33B
| $12.7M | ﹤0.01% |
621,837
+90,071
| +17% | +$2.21M |
|
|
TBI
1909
Trueblue
TBI
$310M
| $12.7M | ﹤0.01% |
570,602
-2,274
| -0.4% | -$54.5K |
|
1910
Denali Therapeutics
DNLI
$3.95B
| $12.7M | ﹤0.01% |
613,964
+14,105
| +2% | +$256K |
|
1911
Tennant Co
TNC
$1.13B
| $12.7M | ﹤0.01% |
243,386
-2,131
| -0.9% | -$130K |
|
|
EXTN
1912
DELISTED
Exterran Corporation
EXTN
| $12.7M | ﹤0.01% |
715,650
+1,258
| +0.2% | +$28.2K |
|
|
STBZ
1913
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $12.6M | ﹤0.01% |
584,254
-12,193
| -2% | -$304K |
|
|
ECHO
1914
DELISTED
Echo Global Logistics, Inc.
ECHO
| $12.6M | ﹤0.01% |
619,769
-8,775
| -1% | -$219K |
|
|
BNFT
1915
DELISTED
Benefitfocus, Inc.
BNFT
| $12.6M | ﹤0.01% |
275,295
-3,083
| -1% | -$129K |
|
|
AIMT
1916
DELISTED
Aimmune Therapeutics
AIMT
| $12.6M | ﹤0.01% |
525,792
-1,978
| -0.4% | -$51.2K |
|
1917
Element Solutions
ESI
$9.17B
| $12.6M | ﹤0.01% |
1,216,806
-8,251
| -0.7% | -$90.9K |
|
|
ACIA
1918
DELISTED
Acacia Communications Inc
ACIA
| $12.5M | ﹤0.01% |
329,854
-1,123
| -0.3% | -$45.4K |
|
|
BNCL
1919
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $12.5M | ﹤0.01% |
875,663
-4,564
| -0.5% | -$70.7K |
|
|
VGR
1920
DELISTED
Vector Group Ltd.
VGR
| $12.5M | ﹤0.01% |
1,901,094
-41,785
| -2% | -$353K |
|
1921
Mativ Holdings
MATV
$706M
| $12.5M | ﹤0.01% |
498,516
-55,171
| -10% | -$1.7M |
|
1922
Pacific Biosciences
PACB
$354M
| $12.5M | ﹤0.01% |
1,687,528
+161,208
| +11% | +$1.02M |
|
1923
Opko Health
OPK
$1.04B
| $12.5M | ﹤0.01% |
4,140,019
-12,498
| -0.3% | -$42.4K |
|
1924
TTM Technologies
TTMI
$13.8B
| $12.5M | ﹤0.01% |
1,280,175
+4,082
| +0.3% | +$50.1K |
|
|
PR
1925
Permian Resources
PR
$18B
| $12.5M | ﹤0.01% |
1,130,234
+10,814
| +1% | +$186K |
|
Similar funds
Northern Trust's Q4 2018 Portfolio in Review
As of Q4 2018, Northern Trust held 4,401 positions worth $357B, down 13% from $409B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 5%. Northern Trust opened 95 new positions and exited 125, leaving the 4,401-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2018 buy was Linde: 6,288,266 shares worth $981M.
- Northern Trust added most to Cigna in Q4 2018, an estimated $524M increase.
- Northern Trust's biggest Q4 2018 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $224M.
- Northern Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $918M.
- Northern Trust's ten largest holdings make up 16% of its $357B portfolio in Q4 2018.
- Northern Trust opened 95 new positions and closed 125 in Q4 2018.
- Northern Trust's portfolio value fell 13% quarter-over-quarter to $357B.
Based on Northern Trust's 13F filing for Q4 2018, filed 12 Feb 2019.